Skymark Research Initiates Independent Research Coverage on Vivakor, Inc.

By admin | December 15, 2009
Rating 3.00 out of 5
[?]

Submitted by SmallCapVoice.com

CALGARY, Alberta, Dec. 15, 2009 (GLOBE NEWSWIRE) — Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Vivakor, Inc. (OTCBB:VIVK). Skymark Research is currently offering a complimentary trial subscription. To view our research go to: www.skymarkresearch.com.

About SMR:

Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research’s staff of small-cap investment professionals is dedicated to providing the small market’s investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.skymarkresearch.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.skymarkresearch.com/signup.php

The Skymark Research logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6683

About Vivakor, Inc. (OTCBB:VIVK)

Vivakor, Inc. (OTCBB:VIVK) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at www.vivakor.com.

SMR Disclosure:

Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, www.skymarkresearch.com, for complete risks and disclosures.

CONTACT: Skymark Research
Dylan Boyle
202-657-6249
info@skymarkresearch.com

Source: GlobeNewswire (December 15, 2009 – 9:03 AM EST)

Visit 1800blogger to see all of our industry leading blogs.

Comments